In contrast to AChE, BDNF levels were lowest in the AD group compared to the HC group (p ≤ 0.0001), while quercetin treatment increased BDNF levels in all groups, demonstrating its protective effect. This evidence concerns the gene BDNF and Alzheimer disease.